T-BOLT Trademark

Trademark Overview


On Tuesday, September 30, 2025, a trademark application was filed for T-BOLT with the United States Patent and Trademark Office. The USPTO has given the T-BOLT trademark a serial number of 99421539. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, March 4, 2026. This trademark is owned by Crossbow Therapeutics, Inc.. The T-BOLT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of cancer and immunological diseases; Medical and scientific research information in the field of cancer and immunological diseases; Pharmaceutical research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the field of cancer and immunological diseases; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and immunological d...
t-bolt

General Information


Serial Number99421539
Word MarkT-BOLT
Filing DateTuesday, September 30, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, March 4, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 24, 2026

Trademark Statements


Goods and ServicesMedical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of cancer and immunological diseases; Medical and scientific research information in the field of cancer and immunological diseases; Pharmaceutical research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the field of cancer and immunological diseases; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and immunological diseases; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Consulting services in the field of pharmaceutical research and development
Pseudo MarkT BOLT

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 30, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCrossbow Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
US

Trademark Events


Event DateEvent Description
Tuesday, September 30, 2025NEW APPLICATION ENTERED
Tuesday, September 30, 2025APPLICATION FILING RECEIPT MAILED
Thursday, February 19, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 20, 2026ASSIGNED TO EXAMINER
Saturday, February 28, 2026APPROVED FOR PUB - PRINCIPAL REGISTER